[Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D016316:Guanfacine; D006146:Guanidines / Q000008:administration & dosage*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications*; D007741:Labetalol / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000008:administration & dosage*
D000959:Antihypertensive Agents; D004983:Ethanolamines; D006146:Guanidines; D010648:Phenylacetates; D016316:Guanfacine; D007741:Labetalol
Primenenie labetalola i guanfatsina dlia lechaniia arterial'noĭ gipertonii u bol'nykh s khronicheskoĭ pochechnoĭ nedostatochnost'iu.